Lakewood Rch, FLORIDA1 Active Studies

Primary Biliary Cholangitis Clinical Trials in Lakewood Rch, FLORIDA

Find 1 actively recruiting primary biliary cholangitis clinical trials in Lakewood Rch, FLORIDA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
150
Enrolling

Recruiting Primary Biliary Cholangitis Studies in Lakewood Rch

About Primary Biliary Cholangitis Clinical Trials in Lakewood Rch

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.

There are currently 1 primary biliary cholangitis clinical trials recruiting participants in Lakewood Rch, FLORIDA. These studies are seeking a combined 150 participants. Research is being sponsored by Zydus Therapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Primary Biliary Cholangitis Clinical Trials in Lakewood Rch — FAQ

Are there primary biliary cholangitis clinical trials in Lakewood Rch?

Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in Lakewood Rch, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lakewood Rch?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lakewood Rch research site will contact you about next steps.

Are clinical trials in Lakewood Rch free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lakewood Rch studies also compensate for your time and travel.

What primary biliary cholangitis treatments are being tested?

The 1 active trials in Lakewood Rch are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.

Data updated March 2, 2026 from ClinicalTrials.gov